+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID07814079

Mapping and Targeted Ablation of Scar Channels for Ventricular Tachycardia in Structural Heart Disease

Led by New York Medical College · Updated on 2026-09-10

30

Participants Needed

1

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

This research aims to identify specific conducting channels within heart scars that cause ventricular tachycardia VT in patients with structural heart disease. The study evaluates how mapping these channels and targeting their exit points with radiofrequency ablation may block VT. Participants are patients undergoing VT ablation who have scars in their hearts related to ischemic or nonischemic cardiomyopathy. Participants will undergo detailed mapping procedures including noninvasive and invasive techniques to locate channel exits within the scar tissue. The study combines noninvasive mapping using Vektor vMap and invasive high-density catheters to pace and map the scar channels and their exits. Ablation energy is then applied to block these exit sites, aiming to isolate the scar channels responsible for VT. Additional ablation may be performed if VT remains inducible after the initial lesion set. During the ablation procedure, researchers will assess the success of substrate isolation by counting participants with blocked exit sites and matching invasive and noninvasive mapping results. They will also evaluate VT inducibility after ablation and follow participants for up to one year to monitor outcomes. The study involves careful mapping, ablation, and follow-up to measure the procedures impact on VT control.

CONDITIONS

Brief Title

Targeted Ablation to Isolate Scar Channels Causing Ventricular Tachycardia

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here